Grinta provides an AI-powered platform designed to automate and optimize the sales development process for B2B organizations. The system leverages machine learning to qualify leads, personalize outreach sequences, and manage prospect engagement at scale. This results in increased pipeline velocity and higher conversion rates for sales teams.
Funding
Funding not disclosed
BVRVFounders
Product
Problem
Independent pharmacies in Africa face challenges in procurement, inventory management, and access to financing, hindering their ability to efficiently serve patients and optimize operational costs. Traditional pharmaceutical supply chains often lack transparency and traceability, leading to inefficiencies and potential risks related to counterfeit or expired products.
Solution
Grinta provides a Fintech-enabled B2B platform that modernizes the pharmaceutical supply chain, offering independent pharmacies access to a wide range of traceable pharmaceutical and medical products from multiple vendors. The platform streamlines procurement with an easy-to-use interface, while also providing demand planning and inventory financing tools to optimize working capital. By connecting all stakeholders across the value chain, Grinta aims to build a data-driven, reliable, and efficient pharmaceutical supply chain, empowering pharmacists to focus on patient care.
Target Audience
The primary target audience is independent pharmacies across Africa seeking to improve their procurement processes, optimize inventory management, and access financing options.
Features
- Digital distribution channel providing access to a full spectrum of pharmaceutical and medical products.
- Automated replenishment system via digital distributors.
- Pharmacy stock and sales management tools.
- Wallets and loyalty programs to incentivize purchases.
- Expired stock and waste management features.
- Automated Vendor Managed Inventory (VMI).
- Peer-to-peer (P2P) access for resource sharing.
- Educational content to support pharmacists.
- Financing and lending options to improve working capital.